oral tirzepatide vs injectable tirzepatide Weight Loss: Risks & Benefits Compounded Tirzepatide: Oral Vs. Injectable
Description
doi: 10.3390/nu15041013
The Food and Drug Administration approved Wegovy, a higher-d...
CLICK BELOW TO PLAY: Your browser does not support the audio element
digestive discomfort
Method A retrospective cohort study of patients who underwent SG between January 2008 and August 2022 and sought treatment for weight recurrence with semaglutide or tirzepetide from January 2022 onwards
Trial Registration Clinicaltrials.gov: NCT02607865 (PIONEER 3), NCT02863419 (PIONEER 4), NCT02827708 (PIONEER 5), NCT02849080 (PIONEER 7) and NCT03021187 (PIONEER 8)
